Cita APA

Elez, E., Calleja, E., Caussé-Amellal, N., Fakih, M., Ciardiello, F., & Prager, G. (2025). Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.

Citación estilo Chicago

Elez, Elena, Elizabeth Calleja, Nadia Caussé-Amellal, Marwan Fakih, Fortunato Ciardiello, y Gerhard Prager. Managing Adverse Events in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/tipiracil in Combination With Bevacizumab. 2025.

Cita MLA

Elez, Elena, et al. Managing Adverse Events in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/tipiracil in Combination With Bevacizumab. 2025.